Equities researchers at StockNews.com began coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a report released on Friday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright raised their price target on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research report on Thursday, December 12th.
Get Our Latest Analysis on SNES
SenesTech Stock Down 8.7 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Ride Out The Recession With These Dividend Kings
- DuPont’s Electronics Spinoff: The Start of Something Big
- Which Wall Street Analysts are the Most Accurate?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
